Member Info for Awonda

US 9,089,535 B2 has been granted in the US but is specifically for people who are also suffering from COPD or Asthma

We claim:
1. A method of treating a patient with a viral-induced exacerbation of a respiratory disorder, the method comprising: administering to the patient a therapeutically effective amount of an agent, wherein the agent comprises:
(a) an interferon-? (IFN-?) polypeptide or
(b) a polynucleotide which expresses an IFN-? polypeptide in a target bronchial epithelial cell,
wherein the administration results in suppression of viral replication causing said viral-induced exacerbation in the patient, and said respiratory disorder is asthma or chronic obstructive pulmonary disease (COPD).

Yes of course. US20110177028A1 was the one that really caught my eye.

Claim 1 was:
1. A method of treating a respiratory tract infection in a non-asthmatic/non-COPD human individual, which comprises airway delivery of an agent selected from the group consisting of:
(i) IFN-ß;
(ii) an agent that increase IFN-ß expression; and
(iii) a polynucleotide that express one or more agents as in (i) or (ii) in human bronchial epithelial cells.

I've known about Synairgen for a long time and have been drawn like a moth by the results and noise around this. So I've done some looking at the patents....
I see dropped patents that covered interferon to the lungs for viral disease., this would in my mind open up the market for others to come in and compete.

Does anyone know which patents if any would stop others doing so?

Are there any patents that prevent anyone else just going ahead and delivering Interferon Beta to the lungs?
I've noticed that some of the related patents are held by Imperial Innovations so I may simply have missed some key patents.

Also it may be that the advantage they have in access to the clinical data would give them a big head start.